Gregory T. Lucier serves as Chief Executive Officer and Chairman of Carlsbad-based Life Technologies, one of the largest providers of systems, biological reagents, and services, supplying scientists around the world in every way that life science technologies are applied, with approx. 9,000 employees and $3.3B in revenues in 2009. Life Technologies was formed from the November 2008 merger of Invitrogen Corp. and Applied Biosystems. Lucier serves on the Board of Directors at Synthetic Genomics, Inc. and Carefusion Corporation, and serves as Chairman of the Board of Trustees of the Sanford Burnham Medical Research Institute.